In Canada, the Food and Drugs Act has been used to control NPS. For example, prior to BZP being added to Schedule III to the CDSA, an individual was charged and found guilty with selling an unapproved drug containing BZP. The Food and Drugs Act (FDA) (R.S.C., 1985, c. F-27) defines a “drug” as any substance or mixture of substances manufactured "restoring, correcting or modifying organic functions in human beings or animals". Accordingly, under the FDA and its regulations, it is illegal to sell a drug that has not been authorized for sale by Health Canada. The penalties associated with illegal activities set out in the FDA are less than those set out in the CDSA. This relative “catch-all” has allowed Canada to deem the sale of several substances to be illegal.